Outcomes of elective head and neck confirmed or suspected cancer surgery during the COVID-19 pandemic.

Autor: Brar S; ENT Department, St George's University Hospital, London, UK. sb1816@my.bristol.ac.uk., Ofo E; ENT Department, St George's University Hospital, London, UK., Hyde N; Oral and Maxillofacial Surgery Department, St George's University Hospital, London, UK., Kim D; ENT Department, St George's University Hospital, London, UK., Odutoye T; ENT Department, St George's University Hospital, London, UK., Allin D; ENT Department, St George's University Hospital, London, UK., Rovira A; ENT Department, St George's University Hospital, London, UK.
Jazyk: angličtina
Zdroj: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2021 Apr; Vol. 278 (4), pp. 1277-1282. Date of Electronic Publication: 2020 Jul 15.
DOI: 10.1007/s00405-020-06194-2
Abstrakt: Purpose: To analyse the complication outcomes of COVID-19 negative patients undergoing elective head and neck surgery during the COVID-19 pandemic.
Methods: This was a retrospective case review of all patients undergoing elective head and neck surgery for confirmed or suspected head and neck cancer.
Results: There were no mortalities recorded in the cohort of patients analysed. At 30 days, pulmonary complications had occurred in 4 patients (9%). None of these were related to COVID infection.
Conclusion: With careful pre-operative screening of patients for COVID-19 and post-operative care in a COVID-19 clean ward, head and neck surgery can proceed safely during the epidemic. This data could help to minimise delay in treatment by allowing a greater number of elective head and neck cancer operations to proceed.
Databáze: MEDLINE